IFOSFAMIDE
These highlights do not include all the information needed to use Ifosfamide for Injection safely and effectively. See full prescribing information for Ifosfamide for Injection. Initial U.S. Approval: 1988
Approved
Approval ID
efb1d03b-2d91-406e-8110-d3a58b8fa7cc
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 30, 2019
Manufacturers
FDA
Baxter Healthcare Corporation
DUNS: 005083209
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ifosfamide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10019-929
Application NumberNDA019763
Product Classification
M
Marketing Category
C73594
G
Generic Name
ifosfamide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 30, 2019
FDA Product Classification
INGREDIENTS (1)
IFOSFAMIDEActive
Quantity: 3 g in 60 mL
Code: UM20QQM95Y
Classification: ACTIB
ifosfamide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10019-927
Application NumberNDA019763
Product Classification
M
Marketing Category
C73594
G
Generic Name
ifosfamide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 30, 2019
FDA Product Classification
INGREDIENTS (1)
IFOSFAMIDEActive
Quantity: 1 g in 20 mL
Code: UM20QQM95Y
Classification: ACTIB